Clinical Trials Directory

Trials / Completed

CompletedNCT01433224

Studying Biomarkers in Samples From Younger Patients With Malignant Germ Cell Tumor Progression

Genomic Signatures of Malignant Germ Cell Tumor Progression: A Retrospective Study of Banked Specimens

Status
Completed
Phase
Study type
Observational
Enrollment
90 (estimated)
Sponsor
Children's Oncology Group · Network
Sex
All
Age
Healthy volunteers
Not accepted

Summary

RATIONALE: Studying samples of blood and tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors find better ways to treat cancer. PURPOSE: This research trial studies samples from younger patients with malignant germ cell tumor progression.

Detailed description

OBJECTIVES: * Explore inter-tumoral heterogeneity in DNA methylation by tumor histology. * Determine the genomic methylation pattern in the tumors. * Correlate methylation pattern with tumor histology and clinical characteristics. * Carry out exome capture and massively parallel sequencing on selected germ cell tumors (GCTs) and matched normal tissue. * Perform exome capture and Solexa sequencing on a selected set of GCTs. * Validate candidate mutations in an independent set of tumors. * Determine the expression profile of mRNAs, lincRNAs and microRNAs in the tumors using RNA Seq. OUTLINE: Archived blood and tumor tissue samples are analyzed for genomic methylation pattern, exome capture and sequencing, and candidate mutations by methylation-specific PCR techniques, single nucleotide polymorphism (SNP) arrays, and Solexa sequencing methods. Results are validated by using pyrosequencing assays and primer-extension assays. Methylation pattern is also associated with each patient's tumor histology and clinical data.

Conditions

Interventions

TypeNameDescription
GENETICDNA methylation analysis
GENETICRNA analysis
GENETICmutation analysis
GENETICnucleic acid sequencing
GENETICpolymerase chain reaction
GENETICpolymorphism analysis
OTHERlaboratory biomarker analysis
OTHERmedical chart review

Timeline

Start date
2011-10-01
Primary completion
2016-05-01
Completion
2016-05-01
First posted
2011-09-13
Last updated
2016-05-18

Source: ClinicalTrials.gov record NCT01433224. Inclusion in this directory is not an endorsement.